Extensively revised from cover to cover, Kendig and Wilmott's Disorders of the Respiratory Tract in Children, 10th Edition, continues to be your #1 choice for reliable, up-to-date information on all aspects of pediatric respiratory disorders. This highly respected reference is accessible to specialists and primary care providers alike, with coverage of both common and less common respiratory problems found in the newborn and child. Detailed and thorough, this edition covers basic science and its relevance to today’s clinical issues as well as treatment, management, and outcomes information, making it an ideal resource for day-to-day practice as well as certification or recertification review and other professional examinations such as pHERMES.
Offers an international perspective on the whole spectrum of the specialty, including a robust video library with demonstrations of key procedures and bronchoscopic views.
Uses a consistent format with succinct, bulleted text, and contains abundant tables and figures, chapter summaries, and more than 500 full-color images to convey key information in an easy-to-digest manner.
Contains eleven new chapters and discusses timely topics such as big data and -omics in respiratory disease, COVID-19, obesity and its consequences, and vaping and nicotine addiction among children and young people.
Provides up-to-date instruction on key procedures, such as bronchoscopy and pulmonary function testing.
Highlights the knowledge and expertise of nearly 90 new authors who are global experts in the fields of pediatrics, pulmonology, neurology, microbiology, cardiology, physiology, diagnostic imaging, critical care, otolaryngology, allergy, and surgery.
1. INTRODUCTION - p. 312 2. CLINICAL APPROACH - p. 312 3. THE SIZE OF THE PROBLEM: EPIDEMIOLOGY OF CONGENITAL MALFORMATIONS OF THE LUNG - p. 313 4. ANTENATAL DIAGNOSIS AND MANAGEMENT OF CONGENITAL LUNG DISEASE - p. 314 5. ANTENATAL DIAGNOSIS OF CONGENITAL LUNG LESIONS - p. 314 6. CONGENITAL ABNORMALITIES OF THE UPPER AIRWAY - p. 324 7. SPECIFIC PROBLEMS: CONGENITAL BRONCHIAL ABNORMALITIES - p. 338 8. SPECIFIC PROBLEMS: PARENCHYMAL LESIONS - p. 340 9. FOREGUT (BRONCHOGENIC) CYSTS (CLINICALLY, CYSTIC CONGENITAL THORACIC MALFORMATIONS) - p. 340 10. CONGENITAL LARGE HYPERLUCENT LOBE - p. 343 11. PREVENTION OF (NON-MALIGNANT) COMPLICATIONS - p. 345 12. OPTIMIZING LUNG GROWTH - p. 346 13. RELATIONSHIP BETWEEN CONGENITAL THORACIC MALFORMATIONS AND MALIGNANT TRANSFORMATION - p. 346 14. ADENOCARCINOMA AND CONGENITAL THORACIC MALFORMATIONS - p. 346 15. SUMMARY AND CONCLUSIONS: WHAT APPROACH IS BEST FOR AN ASYMPTOMATIC CONGENITAL THORACIC MALFORMATION? - p. 347 16. PULMONARY SEQUESTRATION - p. 348 17. SPECIFIC PROBLEMS: OVEREXPANSION, APLASIA AND ECTOPIA - p. 349 18. ECTOPIA - p. 351 19. SPECIFIC PROBLEMS: ABNORMAL CONNECTIONS BETWEEN THE BRONCHIAL TREE AND OTHER STRUCTURES - p. 351 20. OTHER ABNORMAL CONNECTIONS - p. 353 21. SPECIFIC PROBLEMS: CONGENITAL DISEASE OF THE PULMONARY ARTERIAL TREE - p. 353 22. SPECIFIC PROBLEMS: CONGENITAL DISEASE OF THE PULMONARY VENOUS TREE - p. 354 23. SPECIFIC PROBLEMS: ABNORMALITIES OF THE CONNECTIONS BETWEEN THE PULMONARY ARTERIAL AND VENOUS TREES - p. 354 24. SPECIFIC PROBLEMS: CONGENITAL DISEASE OF THE LYMPHATIC TREE - p. 355 25. SPECIFIC PROBLEMS: CONGENITAL DISORDERS OF THE CHEST WALL AND DIAPHRAGM - p. 355 26. SPECIFIC PROBLEMS: CONGENITAL CARDIAC DISORDERS - p. 357 27. SPECIFIC PROBLEMS: MULTISYSTEM CONGENITAL DISORDERS THAT AFFECT THE LUNG - p. 358 28. ROLE OF SPECIFIC INVESTIGATIONS - p. 358 29. SUMMARY AND CONCLUSIONS - p. 359 30. ACKNOWLEDGMENTS - p. 361 31. 22. Respiratory Disorders in the Newborn - p. 363 32. INITIATION OF RESPIRATION AT BIRTH - p. 363 33. FETAL LUNG FLUID - p. 363 34. RESPIRATORY DEPRESSION AT BIRTH - p. 364 35. DELIVERY ROOM RESUSCITATION - p. 364 36. VENTILATORY CONTROL - p. 365 37. RESPIRATORY DISTRESS SYNDROME - p. 367 38. TRANSIENT TACHYPNEA OF THE NEWBORN - p. 372 39. MECONIUM ASPIRATION SYNDROME - p. 373 40. ACUTE RESPIRATORY DISTRESS SYNDROME - p. 374 41. EARLY-ONSET PNEUMONIA - p. 375 42. LATE-ONSET PNEUMONIA - p. 376 43. ASPIRATION PNEUMONIA - p. 377 44. INTERSTITIAL LUNG DISEASE - p. 377 45. PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN - p. 377 46. PULMONARY HYPERTENSION IN BRONCHOPULMONARY DYSPLASIA - p. 380 47. PNEUMOTHORAX - p. 380 48. PNEUMOMEDIASTINUM - p. 381 49. PNEUMOPERICARDIUM - p. 381 50. PULMONARY INTERSTITIAL EMPHYSEMA - p. 382 51. SECONDARY PULMONARY HYPOPLASIA - p. 382 52. PATENT DUCTUS ARTERIOSUS - p. 384 53. PULMONARY EDEMA - p. 385 54. PULMONARY HEMORRHAGE - p. 386 55. UPPER AIRWAY OBSTRUCTION - p. 387 56. GASTROESOPHAGEAL REFLUX - p. 388 57. 23. Bronchopulmonary Dysplasia - p. 389 58. Section 4. Respiratory Infections - p. 404 59. 24. Acute Infections That Produce Upper Airway Obstruction - p. 406 60. 25. Bronchiolitis - p. 419 61. 26. Pneumonia in Children - p. 427 62. 27. New and Emerging Viral Infections of the Lung; Focus on SARS-CoV-2 - p. 440 63. 28. Tuberculosis - p. 449 64. 29. Nontuberculous Mycobacterial Disease - p. 472 65. 30. The Mycoses - p. 481 66. 31. Pertussis and Other Bordetella Infections of the Respiratory Tract - p. 501 67. 32. Toxocariasis, Hydatid Disease of the Lung, Strongyloidiasis, and Pulmonary Paragonimiasis - p. 508 68. Section 5. Asthma and Other Wheezing Disorders - p. 522 69. 33. Epidemiology of Childhood Asthma - p. 524 70. 34. The Immunopathogenesis of Asthma - p. 532 71. 35. Asthma in the Preschool-Age Child - p. 543 72. 36. Wheezing in Older Children: Asthma - p. 553 73. INTRODUCTION - p. 553 74. PATHOLOGY - p. 554 75. PATHOPHYSIOLOGY - p. 555 76. NATURAL HISTORY AND PROGNOSIS - p. 556 77. DIAGNOSIS OF ASTHMA - p. 557 78. APPROACH TO MANAGEMENT - p. 565 79. 37. Severe Asthma - p. 588 80. Section 6. Cystic Fibrosis and Other Causes of Chronic Airway Infection - p. 603 81. 38. Genetics and Pathophysiology of Cystic Fibrosis - p. 604 82. 39. Diagnosis and Presentation of Cystic Fibrosis - p. 616 83. 40. Pulmonary Disease in Cystic Fibrosis - p. 625 84. 41. Nonpulmonary Manifestations of Cystic Fibrosis - p. 636 85. 42. Modern Molecular Therapies for Cystic Fibrosis - p. 647 86. 43. Primary Ciliary Dyskinesia and Other Ciliopathies - p. 657 87. 44. Bronchiectasis and Chronic Suppurative Lung Disease - p. 669 88. INTRODUCTION - p. 669 89. BRONCHIECTASIS AND CHRONIC SUPPURATIVE LUNG DISEASE - p. 670 90. PROTRACTED BACTERIAL BRONCHITIS - p. 690 91. SUMMARY - p. 693 92. ACKNOWLEDGMENT - p. 693 93. Section 7. Diffuse Lung Disease - p. 694 94. 45. New Concepts in Children’s Interstitial and Diffuse Lung Disease - p. 696 95. 46. Rare and Newly Recognized Childhood Lung Disorders - p. 701 96. 47. Childhood Interstitial Lung Disease More Prevalent in Infancy - p. 706 97. 48. Lung Diseases Associated With Disruption of Pulmonary Surfactant Homeostasis - p. 716 98. 49. Pulmonary Involvement in the Systemic Inflammatory Diseases of Childhood - p. 732 99. OVERVIEW OF CHAPTER - p. 732 100. JUVENILE IDIOPATHIC ARTHRITIS - p. 732 101. SYSTEMIC LUPUS ERYTHEMATOSUS - p. 736 102. JUVENILE DERMATOMYOSITIS - p. 739 103. SYSTEMIC SCLEROSIS (SCLERODERMA) - p. 742 104. MIXED CONNECTIVE TISSUE DISEASE - p. 745 105. SARCOIDOSIS - p. 746 106. CHILDHOOD VASCULITIDES - p. 750 107. GRANULOMATOSIS WITH POLYANGIITIS - p. 751 108. OTHER SYSTEMIC INFLAMMATORY DISEASES WITH SIGNIFICANT PULMONARY INVOLVEMENT - p. 754 109. CLINICAL APPROACH TO DIAGNOSIS AND MANAGEMENT OF PULMONARY INVOLVEMENT IN THE SYSTEMIC INFLAMMATORY DISEASES OF CHILDHOOD - p. 756 110. 50. Lung Injury Caused by Pharmacologic Agents - p. 759 111. 51. Diffuse Alveolar Hemorrhage in Children - p. 769 112. 52. Hypersensitivity Pneumonitis and Eosinophilic Lung Diseases - p. 779 113. Section 8. Respiratory Complications in the Immunocompromised Child - p. 787 114. 53. Primary Immunodeficiency and Other Diseases With Immune Dysregulation - p. 788 115. 54. Pulmonary Disease in the Immunosuppressed Pediatric Patient - p. 800 116. 55. Respiratory Disorders in Children and Adolescents Living With HIV - p. 819 117. Section 9. Pulmonary Vascular Disease - p. 832 118. 56. Pulmonary Embolism and Thromboembolic Diseases - p. 834 119. 57. Childhood Pulmonary Arterial Hypertension - p. 843 120. 58. Pulmonary Arteriovenous Malformations - p. 867 121. 59. Pulmonary Lymphatic Disease - p. 872 122. Section 10. The Aerodigestive Model - p. 884 123. 60. The Aerodigestive Model: Improving Health Care for Complex Patients - p. 886 124. 61. Aspiration, Feeding, and Swallowing Disorders - p. 889 125. 62. Gastroesophageal Reflux Disease and Eosinophilic Esophagitis in Children With Complex Airway Disease - p. 905 126. 63. Laryngeal and Tracheal Airway Disorders - p. 909 127. Section 11. Disorders of Paediatric Sleep and Control of Breathing - p. 917 128. 64. Basic Physiological Principles of Sleep and Respiratory Control in Infants and Children - p. 918 129. 65. Testing for Sleep-Disordered Breathing - p. 927 130. 66. Obstructive Sleep Apnea in Children - p. 939 131. 67. Complex Sleep and Hypoventilation Disorders in Children - p. 946 132. 68. Sudden Infant Death Syndrome, Brief Resolved Unexplained Events and Apparent Life-Threatening Events, and Apnea of Prematurity - p. 961 133. Section 12. The Critically Ill Child - p. 983 134. 69. Principles of Mechanical Ventilation - p. 984 135. 70. Pediatric Acute Respiratory Distress Syndrome - p. 997 136. 71. Pulmonary Edema - p. 1007 137. 72. Lung Injury From Hydrocarbon Aspiration and Smoke Inhalation - p. 1021 138. 73. Drowning - p. 1029 139. 74. Trauma of the Thorax - p. 1034 140. 75. Respiratory Complications of Intensive Care - p. 1044 141. Section 13. Miscellaneous Pulmonary Disorders - p. 1054 142. 76. Pulmonary Disease Associated With Congenital Heart Disease - p. 1056 143. 77. The Lung in Sickle Cell Disease - p. 1068 144. 78. Respiratory Complications of Down Syndrome and Other Genetic Syndromes - p. 1076 145. 79. Tumors of the Chest - p. 1093 146. 80. Respiratory Aspects of Neuromuscular Disorders - p. 1114 147. 81. Air and Fluid in the Pleural Space, and Atelectasis - p. 1123 148. Section 14. Emerging Threats to Children’s Lung Health - p. 1147 149. 82. Environmental Contributions to Respiratory Disease in Children - p. 1148 150. 83. Combustible and Electronic Cigarettes: Tobacco and Marijuana Use in Children and Adolescents - p. 1159 151. INDEX - p. 1167
Extensively revised from cover to cover, Kendig and Wilmott's Disorders of the Respiratory Tract in Children, 10th Edition, continues to be your #1 choice for reliable, up-to-date information on all aspects of pediatric respiratory disorders. This highly respected reference is accessible to specialists and primary care providers alike, with coverage of both common and less common respiratory problems found in the newborn and child. Detailed and thorough, this edition covers basic science and its relevance to today’s clinical issues as well as treatment, management, and outcomes information, making it an ideal resource for day-to-day practice as well as certification or recertification review and other professional examinations such as pHERMES.
Offers an international perspective on the whole spectrum of the specialty, including a robust video library with demonstrations of key procedures and bronchoscopic views.
Uses a consistent format with succinct, bulleted text, and contains abundant tables and figures, chapter summaries, and more than 500 full-color images to convey key information in an easy-to-digest manner.
Contains eleven new chapters and discusses timely topics such as big data and -omics in respiratory disease, COVID-19, obesity and its consequences, and vaping and nicotine addiction among children and young people.
Provides up-to-date instruction on key procedures, such as bronchoscopy and pulmonary function testing.
Highlights the knowledge and expertise of nearly 90 new authors who are global experts in the fields of pediatrics, pulmonology, neurology, microbiology, cardiology, physiology, diagnostic imaging, critical care, otolaryngology, allergy, and surgery.
1. INTRODUCTION - p. 312 2. CLINICAL APPROACH - p. 312 3. THE SIZE OF THE PROBLEM: EPIDEMIOLOGY OF CONGENITAL MALFORMATIONS OF THE LUNG - p. 313 4. ANTENATAL DIAGNOSIS AND MANAGEMENT OF CONGENITAL LUNG DISEASE - p. 314 5. ANTENATAL DIAGNOSIS OF CONGENITAL LUNG LESIONS - p. 314 6. CONGENITAL ABNORMALITIES OF THE UPPER AIRWAY - p. 324 7. SPECIFIC PROBLEMS: CONGENITAL BRONCHIAL ABNORMALITIES - p. 338 8. SPECIFIC PROBLEMS: PARENCHYMAL LESIONS - p. 340 9. FOREGUT (BRONCHOGENIC) CYSTS (CLINICALLY, CYSTIC CONGENITAL THORACIC MALFORMATIONS) - p. 340 10. CONGENITAL LARGE HYPERLUCENT LOBE - p. 343 11. PREVENTION OF (NON-MALIGNANT) COMPLICATIONS - p. 345 12. OPTIMIZING LUNG GROWTH - p. 346 13. RELATIONSHIP BETWEEN CONGENITAL THORACIC MALFORMATIONS AND MALIGNANT TRANSFORMATION - p. 346 14. ADENOCARCINOMA AND CONGENITAL THORACIC MALFORMATIONS - p. 346 15. SUMMARY AND CONCLUSIONS: WHAT APPROACH IS BEST FOR AN ASYMPTOMATIC CONGENITAL THORACIC MALFORMATION? - p. 347 16. PULMONARY SEQUESTRATION - p. 348 17. SPECIFIC PROBLEMS: OVEREXPANSION, APLASIA AND ECTOPIA - p. 349 18. ECTOPIA - p. 351 19. SPECIFIC PROBLEMS: ABNORMAL CONNECTIONS BETWEEN THE BRONCHIAL TREE AND OTHER STRUCTURES - p. 351 20. OTHER ABNORMAL CONNECTIONS - p. 353 21. SPECIFIC PROBLEMS: CONGENITAL DISEASE OF THE PULMONARY ARTERIAL TREE - p. 353 22. SPECIFIC PROBLEMS: CONGENITAL DISEASE OF THE PULMONARY VENOUS TREE - p. 354 23. SPECIFIC PROBLEMS: ABNORMALITIES OF THE CONNECTIONS BETWEEN THE PULMONARY ARTERIAL AND VENOUS TREES - p. 354 24. SPECIFIC PROBLEMS: CONGENITAL DISEASE OF THE LYMPHATIC TREE - p. 355 25. SPECIFIC PROBLEMS: CONGENITAL DISORDERS OF THE CHEST WALL AND DIAPHRAGM - p. 355 26. SPECIFIC PROBLEMS: CONGENITAL CARDIAC DISORDERS - p. 357 27. SPECIFIC PROBLEMS: MULTISYSTEM CONGENITAL DISORDERS THAT AFFECT THE LUNG - p. 358 28. ROLE OF SPECIFIC INVESTIGATIONS - p. 358 29. SUMMARY AND CONCLUSIONS - p. 359 30. ACKNOWLEDGMENTS - p. 361 31. 22. Respiratory Disorders in the Newborn - p. 363 32. INITIATION OF RESPIRATION AT BIRTH - p. 363 33. FETAL LUNG FLUID - p. 363 34. RESPIRATORY DEPRESSION AT BIRTH - p. 364 35. DELIVERY ROOM RESUSCITATION - p. 364 36. VENTILATORY CONTROL - p. 365 37. RESPIRATORY DISTRESS SYNDROME - p. 367 38. TRANSIENT TACHYPNEA OF THE NEWBORN - p. 372 39. MECONIUM ASPIRATION SYNDROME - p. 373 40. ACUTE RESPIRATORY DISTRESS SYNDROME - p. 374 41. EARLY-ONSET PNEUMONIA - p. 375 42. LATE-ONSET PNEUMONIA - p. 376 43. ASPIRATION PNEUMONIA - p. 377 44. INTERSTITIAL LUNG DISEASE - p. 377 45. PERSISTENT PULMONARY HYPERTENSION OF THE NEWBORN - p. 377 46. PULMONARY HYPERTENSION IN BRONCHOPULMONARY DYSPLASIA - p. 380 47. PNEUMOTHORAX - p. 380 48. PNEUMOMEDIASTINUM - p. 381 49. PNEUMOPERICARDIUM - p. 381 50. PULMONARY INTERSTITIAL EMPHYSEMA - p. 382 51. SECONDARY PULMONARY HYPOPLASIA - p. 382 52. PATENT DUCTUS ARTERIOSUS - p. 384 53. PULMONARY EDEMA - p. 385 54. PULMONARY HEMORRHAGE - p. 386 55. UPPER AIRWAY OBSTRUCTION - p. 387 56. GASTROESOPHAGEAL REFLUX - p. 388 57. 23. Bronchopulmonary Dysplasia - p. 389 58. Section 4. Respiratory Infections - p. 404 59. 24. Acute Infections That Produce Upper Airway Obstruction - p. 406 60. 25. Bronchiolitis - p. 419 61. 26. Pneumonia in Children - p. 427 62. 27. New and Emerging Viral Infections of the Lung; Focus on SARS-CoV-2 - p. 440 63. 28. Tuberculosis - p. 449 64. 29. Nontuberculous Mycobacterial Disease - p. 472 65. 30. The Mycoses - p. 481 66. 31. Pertussis and Other Bordetella Infections of the Respiratory Tract - p. 501 67. 32. Toxocariasis, Hydatid Disease of the Lung, Strongyloidiasis, and Pulmonary Paragonimiasis - p. 508 68. Section 5. Asthma and Other Wheezing Disorders - p. 522 69. 33. Epidemiology of Childhood Asthma - p. 524 70. 34. The Immunopathogenesis of Asthma - p. 532 71. 35. Asthma in the Preschool-Age Child - p. 543 72. 36. Wheezing in Older Children: Asthma - p. 553 73. INTRODUCTION - p. 553 74. PATHOLOGY - p. 554 75. PATHOPHYSIOLOGY - p. 555 76. NATURAL HISTORY AND PROGNOSIS - p. 556 77. DIAGNOSIS OF ASTHMA - p. 557 78. APPROACH TO MANAGEMENT - p. 565 79. 37. Severe Asthma - p. 588 80. Section 6. Cystic Fibrosis and Other Causes of Chronic Airway Infection - p. 603 81. 38. Genetics and Pathophysiology of Cystic Fibrosis - p. 604 82. 39. Diagnosis and Presentation of Cystic Fibrosis - p. 616 83. 40. Pulmonary Disease in Cystic Fibrosis - p. 625 84. 41. Nonpulmonary Manifestations of Cystic Fibrosis - p. 636 85. 42. Modern Molecular Therapies for Cystic Fibrosis - p. 647 86. 43. Primary Ciliary Dyskinesia and Other Ciliopathies - p. 657 87. 44. Bronchiectasis and Chronic Suppurative Lung Disease - p. 669 88. INTRODUCTION - p. 669 89. BRONCHIECTASIS AND CHRONIC SUPPURATIVE LUNG DISEASE - p. 670 90. PROTRACTED BACTERIAL BRONCHITIS - p. 690 91. SUMMARY - p. 693 92. ACKNOWLEDGMENT - p. 693 93. Section 7. Diffuse Lung Disease - p. 694 94. 45. New Concepts in Children’s Interstitial and Diffuse Lung Disease - p. 696 95. 46. Rare and Newly Recognized Childhood Lung Disorders - p. 701 96. 47. Childhood Interstitial Lung Disease More Prevalent in Infancy - p. 706 97. 48. Lung Diseases Associated With Disruption of Pulmonary Surfactant Homeostasis - p. 716 98. 49. Pulmonary Involvement in the Systemic Inflammatory Diseases of Childhood - p. 732 99. OVERVIEW OF CHAPTER - p. 732 100. JUVENILE IDIOPATHIC ARTHRITIS - p. 732 101. SYSTEMIC LUPUS ERYTHEMATOSUS - p. 736 102. JUVENILE DERMATOMYOSITIS - p. 739 103. SYSTEMIC SCLEROSIS (SCLERODERMA) - p. 742 104. MIXED CONNECTIVE TISSUE DISEASE - p. 745 105. SARCOIDOSIS - p. 746 106. CHILDHOOD VASCULITIDES - p. 750 107. GRANULOMATOSIS WITH POLYANGIITIS - p. 751 108. OTHER SYSTEMIC INFLAMMATORY DISEASES WITH SIGNIFICANT PULMONARY INVOLVEMENT - p. 754 109. CLINICAL APPROACH TO DIAGNOSIS AND MANAGEMENT OF PULMONARY INVOLVEMENT IN THE SYSTEMIC INFLAMMATORY DISEASES OF CHILDHOOD - p. 756 110. 50. Lung Injury Caused by Pharmacologic Agents - p. 759 111. 51. Diffuse Alveolar Hemorrhage in Children - p. 769 112. 52. Hypersensitivity Pneumonitis and Eosinophilic Lung Diseases - p. 779 113. Section 8. Respiratory Complications in the Immunocompromised Child - p. 787 114. 53. Primary Immunodeficiency and Other Diseases With Immune Dysregulation - p. 788 115. 54. Pulmonary Disease in the Immunosuppressed Pediatric Patient - p. 800 116. 55. Respiratory Disorders in Children and Adolescents Living With HIV - p. 819 117. Section 9. Pulmonary Vascular Disease - p. 832 118. 56. Pulmonary Embolism and Thromboembolic Diseases - p. 834 119. 57. Childhood Pulmonary Arterial Hypertension - p. 843 120. 58. Pulmonary Arteriovenous Malformations - p. 867 121. 59. Pulmonary Lymphatic Disease - p. 872 122. Section 10. The Aerodigestive Model - p. 884 123. 60. The Aerodigestive Model: Improving Health Care for Complex Patients - p. 886 124. 61. Aspiration, Feeding, and Swallowing Disorders - p. 889 125. 62. Gastroesophageal Reflux Disease and Eosinophilic Esophagitis in Children With Complex Airway Disease - p. 905 126. 63. Laryngeal and Tracheal Airway Disorders - p. 909 127. Section 11. Disorders of Paediatric Sleep and Control of Breathing - p. 917 128. 64. Basic Physiological Principles of Sleep and Respiratory Control in Infants and Children - p. 918 129. 65. Testing for Sleep-Disordered Breathing - p. 927 130. 66. Obstructive Sleep Apnea in Children - p. 939 131. 67. Complex Sleep and Hypoventilation Disorders in Children - p. 946 132. 68. Sudden Infant Death Syndrome, Brief Resolved Unexplained Events and Apparent Life-Threatening Events, and Apnea of Prematurity - p. 961 133. Section 12. The Critically Ill Child - p. 983 134. 69. Principles of Mechanical Ventilation - p. 984 135. 70. Pediatric Acute Respiratory Distress Syndrome - p. 997 136. 71. Pulmonary Edema - p. 1007 137. 72. Lung Injury From Hydrocarbon Aspiration and Smoke Inhalation - p. 1021 138. 73. Drowning - p. 1029 139. 74. Trauma of the Thorax - p. 1034 140. 75. Respiratory Complications of Intensive Care - p. 1044 141. Section 13. Miscellaneous Pulmonary Disorders - p. 1054 142. 76. Pulmonary Disease Associated With Congenital Heart Disease - p. 1056 143. 77. The Lung in Sickle Cell Disease - p. 1068 144. 78. Respiratory Complications of Down Syndrome and Other Genetic Syndromes - p. 1076 145. 79. Tumors of the Chest - p. 1093 146. 80. Respiratory Aspects of Neuromuscular Disorders - p. 1114 147. 81. Air and Fluid in the Pleural Space, and Atelectasis - p. 1123 148. Section 14. Emerging Threats to Children’s Lung Health - p. 1147 149. 82. Environmental Contributions to Respiratory Disease in Children - p. 1148 150. 83. Combustible and Electronic Cigarettes: Tobacco and Marijuana Use in Children and Adolescents - p. 1159 151. INDEX - p. 1167
